Annual FCF
-$2.29 M
+$3.78 M+62.26%
August 31, 2023
Summary
- As of February 10, 2025, NVOS annual free cash flow is -$2.29 million, with the most recent change of +$3.78 million (+62.26%) on August 31, 2023.
- During the last 3 years, NVOS annual FCF has fallen by -$1.84 million (-405.18%).
- NVOS annual FCF is now -2924.41% below its all-time high of -$75.80 thousand, reached on December 31, 2004.
Performance
NVOS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$660.00 K
+$1.05 M+61.48%
May 31, 2024
Summary
- As of February 10, 2025, NVOS quarterly free cash flow is -$660.00 thousand, with the most recent change of +$1.05 million (+61.48%) on May 31, 2024.
- Over the past year, NVOS quarterly FCF has increased by +$216.60 thousand (+24.71%).
- NVOS quarterly FCF is now -197.55% below its all-time high of $676.60 thousand, reached on August 31, 2022.
Performance
NVOS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$4.79 M
+$216.60 K+4.33%
May 31, 2024
Summary
- As of February 10, 2025, NVOS TTM free cash flow is -$4.79 million, with the most recent change of +$216.60 thousand (+4.33%) on May 31, 2024.
- Over the past year, NVOS TTM FCF has dropped by -$3.43 million (-252.68%).
- NVOS TTM FCF is now -23588.61% below its all-time high of -$20.20 thousand, reached on March 31, 2005.
Performance
NVOS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NVOS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.3% | +24.7% | -252.7% |
| 3 y3 years | -405.2% | -137.2% | +12.6% |
| 5 y5 years | -106.0% | -137.2% | +12.6% |
NVOS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -79.0% | +62.3% | -197.6% | +81.4% | -252.7% | +36.6% |
| 5 y | 5-year | -405.2% | +62.3% | -197.6% | +81.4% | -1475.1% | +36.6% |
| alltime | all time | -2924.4% | +62.3% | -197.6% | +81.4% | <-9999.0% | +36.6% |
Novo Integrated Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2024 | - | -$660.00 K(-61.5%) | -$4.79 M(-4.3%) |
| Feb 2024 | - | -$1.71 M(-20.4%) | -$5.00 M(+20.0%) |
| Nov 2023 | - | -$2.15 M(+730.7%) | -$4.17 M(+81.8%) |
| Aug 2023 | -$2.29 M(-62.3%) | -$259.10 K(-70.4%) | -$2.29 M(+69.0%) |
| May 2023 | - | -$876.60 K(-0.2%) | -$1.36 M(-66.3%) |
| Feb 2023 | - | -$878.60 K(+215.8%) | -$4.03 M(-26.4%) |
| Nov 2022 | - | -$278.20 K(-141.1%) | -$5.47 M(-9.9%) |
| Aug 2022 | -$6.07 M(+374.3%) | $676.60 K(-119.1%) | -$6.07 M(-19.6%) |
| May 2022 | - | -$3.55 M(+52.8%) | -$7.55 M(+86.3%) |
| Feb 2022 | - | -$2.32 M(+164.1%) | -$4.05 M(+101.4%) |
| Nov 2021 | - | -$879.50 K(+9.9%) | -$2.01 M(+57.1%) |
| Aug 2021 | -$1.28 M(+182.2%) | -$800.10 K(+1490.7%) | -$1.28 M(+153.9%) |
| May 2021 | - | -$50.30 K(-82.2%) | -$504.50 K(+66.1%) |
| Feb 2021 | - | -$282.30 K(+90.6%) | -$303.80 K(-0.1%) |
| Nov 2020 | - | -$148.10 K(+522.3%) | -$304.00 K(-33.0%) |
| Aug 2020 | -$453.80 K(-51.2%) | -$23.80 K(-115.8%) | -$453.80 K(-37.5%) |
| May 2020 | - | $150.40 K(-153.2%) | -$725.90 K(-25.5%) |
| Feb 2020 | - | -$282.50 K(-5.2%) | -$974.80 K(-1.6%) |
| Nov 2019 | - | -$297.90 K(+0.7%) | -$990.40 K(+6.5%) |
| Aug 2019 | -$929.90 K(-16.5%) | -$295.90 K(+200.4%) | -$929.90 K(+13.0%) |
| May 2019 | - | -$98.50 K(-67.0%) | -$823.10 K(-27.2%) |
| Feb 2019 | - | -$298.10 K(+25.6%) | -$1.13 M(+13.7%) |
| Nov 2018 | - | -$237.40 K(+25.5%) | -$994.40 K(-10.7%) |
| Aug 2018 | -$1.11 M(+31.1%) | -$189.10 K(-53.4%) | -$1.11 M(+20.5%) |
| May 2018 | - | -$405.60 K(+149.9%) | -$924.00 K(+78.2%) |
| Feb 2018 | - | -$162.30 K(-54.4%) | -$518.40 K(+26.4%) |
| Nov 2017 | - | -$356.10 K(+559.4%) | -$410.10 K(+186.4%) |
| Aug 2017 | -$848.90 K(+673.1%) | - | - |
| Mar 2017 | - | -$54.00 K(+129.8%) | -$143.20 K(+30.4%) |
| Dec 2016 | -$109.80 K(-37.5%) | -$23.50 K(+19.3%) | -$109.80 K(+8.8%) |
| Sep 2016 | - | -$19.70 K(-57.2%) | -$100.90 K(-22.8%) |
| Jun 2016 | - | -$46.00 K(+123.3%) | -$130.70 K(-23.2%) |
| Mar 2016 | - | -$20.60 K(+41.1%) | -$170.10 K(-3.1%) |
| Dec 2015 | -$175.60 K(+20.3%) | -$14.60 K(-70.5%) | -$175.50 K(-12.8%) |
| Sep 2015 | - | -$49.50 K(-42.0%) | -$201.20 K(+10.2%) |
| Jun 2015 | - | -$85.40 K(+228.5%) | -$182.60 K(+41.6%) |
| Mar 2015 | - | -$26.00 K(-35.5%) | -$129.00 K(-11.0%) |
| Dec 2014 | -$146.00 K | -$40.30 K(+30.4%) | -$145.00 K(0.0%) |
| Sep 2014 | - | -$30.90 K(-2.8%) | -$145.00 K(-21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$31.80 K(-24.3%) | -$184.40 K(-23.8%) |
| Mar 2014 | - | -$42.00 K(+4.2%) | -$242.10 K(-2.9%) |
| Dec 2013 | -$249.30 K(-31.7%) | -$40.30 K(-42.7%) | -$249.40 K(-1.8%) |
| Sep 2013 | - | -$70.30 K(-21.5%) | -$254.00 K(+5.9%) |
| Jun 2013 | - | -$89.50 K(+81.5%) | -$239.80 K(-11.2%) |
| Mar 2013 | - | -$49.30 K(+9.8%) | -$269.90 K(-26.1%) |
| Dec 2012 | -$365.10 K(-19.8%) | -$44.90 K(-20.0%) | -$365.10 K(+0.1%) |
| Sep 2012 | - | -$56.10 K(-53.1%) | -$364.70 K(+6.0%) |
| Jun 2012 | - | -$119.60 K(-17.2%) | -$344.00 K(-6.0%) |
| Mar 2012 | - | -$144.50 K(+224.7%) | -$366.10 K(-19.6%) |
| Dec 2011 | -$455.40 K(-72.5%) | -$44.50 K(+25.7%) | -$455.50 K(-30.1%) |
| Sep 2011 | - | -$35.40 K(-75.0%) | -$651.30 K(-27.4%) |
| Jun 2011 | - | -$141.70 K(-39.4%) | -$897.20 K(-36.7%) |
| Mar 2011 | - | -$233.90 K(-2.7%) | -$1.42 M(-14.5%) |
| Dec 2010 | -$1.66 M(+74.0%) | -$240.30 K(-14.6%) | -$1.66 M(-6.4%) |
| Sep 2010 | - | -$281.30 K(-57.6%) | -$1.77 M(+1.8%) |
| Jun 2010 | - | -$662.70 K(+39.7%) | -$1.74 M(+45.3%) |
| Mar 2010 | - | -$474.50 K(+33.9%) | -$1.20 M(+25.9%) |
| Dec 2009 | -$953.50 K(+210.0%) | -$354.40 K(+41.5%) | -$951.80 K(+44.7%) |
| Sep 2009 | - | -$250.40 K(+110.1%) | -$657.70 K(+30.2%) |
| Jun 2009 | - | -$119.20 K(-47.7%) | -$505.10 K(+0.4%) |
| Mar 2009 | - | -$227.80 K(+277.8%) | -$503.00 K(+63.5%) |
| Dec 2008 | -$307.60 K(-41.1%) | -$60.30 K(-38.3%) | -$307.60 K(-26.7%) |
| Sep 2008 | - | -$97.80 K(-16.5%) | -$419.80 K(-0.5%) |
| Jun 2008 | - | -$117.10 K(+261.4%) | -$422.10 K(+6.8%) |
| Mar 2008 | - | -$32.40 K(-81.2%) | -$395.10 K(-24.4%) |
| Dec 2007 | -$522.30 K(+13.9%) | -$172.50 K(+72.3%) | -$522.30 K(+25.8%) |
| Sep 2007 | - | -$100.10 K(+11.1%) | -$415.10 K(-6.3%) |
| Jun 2007 | - | -$90.10 K(-43.5%) | -$442.90 K(-18.9%) |
| Mar 2007 | - | -$159.60 K(+144.4%) | -$546.00 K(+19.0%) |
| Dec 2006 | -$458.70 K(+270.5%) | -$65.30 K(-48.9%) | -$458.80 K(+9.3%) |
| Sep 2006 | - | -$127.90 K(-33.8%) | -$419.60 K(+34.1%) |
| Jun 2006 | - | -$193.20 K(+166.9%) | -$312.80 K(+77.7%) |
| Mar 2006 | - | -$72.40 K(+177.4%) | -$176.00 K(+42.2%) |
| Dec 2005 | -$123.80 K(+63.3%) | -$26.10 K(+23.7%) | -$123.80 K(+26.7%) |
| Sep 2005 | - | -$21.10 K(-62.6%) | -$97.70 K(+27.5%) |
| Jun 2005 | - | -$56.40 K(+179.2%) | -$76.60 K(+279.2%) |
| Mar 2005 | - | -$20.20 K | -$20.20 K |
| Dec 2004 | -$75.80 K | - | - |
FAQ
- What is Novo Integrated Sciences annual free cash flow?
- What is the all time high annual FCF for Novo Integrated Sciences?
- What is Novo Integrated Sciences annual FCF year-on-year change?
- What is Novo Integrated Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Novo Integrated Sciences?
- What is Novo Integrated Sciences quarterly FCF year-on-year change?
- What is Novo Integrated Sciences TTM free cash flow?
- What is the all time high TTM FCF for Novo Integrated Sciences?
- What is Novo Integrated Sciences TTM FCF year-on-year change?
What is Novo Integrated Sciences annual free cash flow?
The current annual FCF of NVOS is -$2.29 M
What is the all time high annual FCF for Novo Integrated Sciences?
Novo Integrated Sciences all-time high annual free cash flow is -$75.80 K
What is Novo Integrated Sciences annual FCF year-on-year change?
Over the past year, NVOS annual free cash flow has changed by +$3.78 M (+62.26%)
What is Novo Integrated Sciences quarterly free cash flow?
The current quarterly FCF of NVOS is -$660.00 K
What is the all time high quarterly FCF for Novo Integrated Sciences?
Novo Integrated Sciences all-time high quarterly free cash flow is $676.60 K
What is Novo Integrated Sciences quarterly FCF year-on-year change?
Over the past year, NVOS quarterly free cash flow has changed by +$216.60 K (+24.71%)
What is Novo Integrated Sciences TTM free cash flow?
The current TTM FCF of NVOS is -$4.79 M
What is the all time high TTM FCF for Novo Integrated Sciences?
Novo Integrated Sciences all-time high TTM free cash flow is -$20.20 K
What is Novo Integrated Sciences TTM FCF year-on-year change?
Over the past year, NVOS TTM free cash flow has changed by -$3.43 M (-252.68%)